Development of an engineered peptide antagonist against periostin to overcome doxorubicin resistance in breast cancer

BACKGROUND: Chemoresistance is one of the main problems in treatment of cancer. Periostin (PN) is a stromal protein which is mostly secreted from cancer associated fibroblasts in the tumor microenvironment and can promote cancer progression including cell survival, metastasis, and chemoresistance. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Oo, Khine Kyaw, Kamolhan, Thanpawee, Soni, Anish, Thongchot, Suyanee, Mitrpant, Chalermchai, O-charoenrat, Pornchai, Thuwajit, Chanitra, Thuwajit, Peti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807878/
https://www.ncbi.nlm.nih.gov/pubmed/33446140
http://dx.doi.org/10.1186/s12885-020-07761-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807878/
https://www.ncbi.nlm.nih.gov/pubmed/33446140
http://dx.doi.org/10.1186/s12885-020-07761-w

Ejemplares similares